These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2516889)

  • 1. Hyperparathyroidism does not influence the abnormal primary haemostasis in patients with chronic renal failure.
    Viganò G; Gotti E; Comberti E; Giangrande A; Trevisan R; Remuzzi G
    Nephrol Dial Transplant; 1989; 4(11):971-4. PubMed ID: 2516889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism.
    Reichel H; Deibert B; Schmidt-Gayk H; Ritz E
    Nephrol Dial Transplant; 1991; 6(3):162-9. PubMed ID: 1866044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function.
    Messa P; Mioni G; Turrin D; Guerra UP
    Nephrol Dial Transplant; 1995 Dec; 10(12):2259-65. PubMed ID: 8808222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
    Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
    Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure.
    Raine AE; Bedford L; Simpson AW; Ashley CC; Brown R; Woodhead JS; Ledingham JG
    Kidney Int; 1993 Mar; 43(3):700-5. PubMed ID: 8455369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D3 in patients on maintenance haemodialysis.
    Rassoul Z; Mousa D; Rehman MA; Abdalla AH; Hawas F; Popovich W; Gaisoum M; al-Sulaiman M; Al-Khader A
    Am J Nephrol; 1995; 15(6):507-11. PubMed ID: 8546173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal calcaemic response to PTH in the uraemic rat without secondary hyperparathyroidism.
    Berdud I; Martin-Malo A; Almaden Y; Tallon S; Concepcion MT; Torres A; Felsenfeld A; Aljama P; Rodriguez M
    Nephrol Dial Transplant; 1996 Jul; 11(7):1292-8. PubMed ID: 8672025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
    Kaczirek K; Prager G; Riss P; Wunderer G; Asari R; Scheuba C; Bieglmayer C; Niederle B
    Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frusemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency.
    Reichel H; Deibert B; Geberth S; Schmidt-Gayk H; Ritz E
    Nephrol Dial Transplant; 1992; 7(1):8-15. PubMed ID: 1316586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of C-terminal and N-terminal PTH in secondary hyperparathyroidism in renal failure.
    Hortling L; Puutula-Räsänen L; Fyhrquist F
    Scand J Urol Nephrol Suppl; 1985; 90():51-4. PubMed ID: 3868028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values.
    Brossard JH; Cloutier M; Roy L; Lepage R; Gascon-Barré M; D'Amour P
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3923-9. PubMed ID: 8923839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperparathyroidism, glucose tolerance and platelet intracellular free calcium in chronic renal failure.
    Lu KC; Shieh SD; Lin SH; Chyr SH; Lin YF; Diang LK; Li BL; Sheu WH; Ding YA
    Q J Med; 1994 Jun; 87(6):359-65. PubMed ID: 8041868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism.
    Goodman WG; Frazao JM; Goodkin DA; Turner SA; Liu W; Coburn JW
    Kidney Int; 2000 Jul; 58(1):436-45. PubMed ID: 10886592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of parathyroid hormone on serum magnesium levels: the neglected relationship in hemodialysis patients with secondary hyperparathyroidism.
    Fang L; Tang B; Hou D; Meng M; Xiong M; Yang J
    Ren Fail; 2016; 38(1):50-6. PubMed ID: 26671274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of carboxyl-terminal parathyroid hormone circulating forms in patients with hyperparathyroidism due to end stage renal disease.
    Vieira JG; Kunii IS; Ohe MN; Carvalho AB
    Arq Bras Endocrinol Metabol; 2009 Dec; 53(9):1074-8. PubMed ID: 20126864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of calcium and 1,25 dihydroxyvitamin D on the level of parathyroid hormone in patients with secondary hyperparathyroidism due to chronic renal insufficiency.
    Vucković S; Paunković N
    Med Pregl; 1993; 46 Suppl 1():40-2. PubMed ID: 8569602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.
    Moe SM; Cunningham J; Bommer J; Adler S; Rosansky SJ; Urena-Torres P; Albizem MB; Guo MD; Zani VJ; Goodman WG; Sprague SM
    Nephrol Dial Transplant; 2005 Oct; 20(10):2186-93. PubMed ID: 16030053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular basis of secondary hyperparathyroidism in chronic renal failure.
    Rahamimov R; Silver J
    Isr J Med Sci; 1994 Jan; 30(1):26-31. PubMed ID: 8138394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of inorganic sulphate in the pathogenesis of hyperparathyroidism in chronic renal failure.
    Michalk D; Tschöpe W; Böhles HJ; Mehls O
    Proc Eur Dial Transplant Assoc; 1981; 18():561-6. PubMed ID: 7329984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.